聖路加国際病院は、東京都中央区にある病院である。事業主体は、日本聖公会系列の学校法人聖路加国際大学。なお、「せいろかこくさいびょういん」は正式な読みではない。

During the past decade, St. Luke's Internat. Hospital, Breast Surgical Oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Internat. Hospital, Breast Surgical Oncology" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "St. Luke's Internat. Hospital, Breast Surgical Oncology" are "Breast Cancer" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials), "Triple Negative Breast Cancer" (1 trials) and "Triple-negative Breast Cancer" (1 trials). Many other conditions were trialed in "St. Luke's Internat. Hospital, Breast Surgical Oncology" in a lesser frequency.

Most popular intervention types in "St. Luke's Internat. Hospital, Breast Surgical Oncology" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Docetaxel" (2 trials), "Doxorubicin" (2 trials), "Paclitaxel" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Internat. Hospital, Breast Surgical Oncology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "St. Luke's Internat. Hospital, Breast Surgical Oncology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in St. Luke's Internat. Hospital, Breast Surgical Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Internat. Hospital, Breast Surgical Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".